OLY Stock Overview
Manufactures and sells precision machineries and instruments worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Olympus Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥14.50 |
| 52 Week High | JP¥17.20 |
| 52 Week Low | JP¥13.30 |
| Beta | 0.62 |
| 11 Month Change | -11.59% |
| 3 Month Change | -7.64% |
| 1 Year Change | n/a |
| 33 Year Change | -26.77% |
| 5 Year Change | n/a |
| Change since IPO | -16.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| OLY | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -1.4% | -2.5% | -1.3% |
| 1Y | n/a | -8.4% | 7.4% |
Return vs Industry: Insufficient data to determine how OLY performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how OLY performed against the German Market.
Price Volatility
| OLY volatility | |
|---|---|
| OLY Average Weekly Movement | 3.1% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: OLY has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: OLY's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 28,838 | n/a | www.olympus-global.com |
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services.
Olympus Corporation Fundamentals Summary
| OLY fundamental statistics | |
|---|---|
| Market cap | €17.38b |
| Earnings (TTM) | €541.67m |
| Revenue (TTM) | €6.01b |
32.1x
P/E Ratio2.9x
P/S RatioIs OLY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OLY income statement (TTM) | |
|---|---|
| Revenue | JP¥973.60b |
| Cost of Revenue | JP¥313.95b |
| Gross Profit | JP¥659.64b |
| Other Expenses | JP¥571.92b |
| Earnings | JP¥87.73b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 77.25 |
| Gross Margin | 67.75% |
| Net Profit Margin | 9.01% |
| Debt/Equity Ratio | 34.9% |
How did OLY perform over the long term?
See historical performance and comparison